Morepen Laboratories reports net sales revenue of Rs 196.60 crore in Q2’FY 2019-20 EP News Bureau Nov 14, 2019 The company's pharma division commenced commercial sales of its probiotics in India during Q1 FY 2019-20 and has made steady…
Morepen Labs adds three new drugs to its API Portfolio EP News Bureau Oct 14, 2019 The three bulk drugs/APIs are Rivaroxaban, Vildagliptin and UDCA will augment Morepen’s presence in the cardiac and diabetic…
Morepen Labs’ Net Profit rises by 256 per cent led by higher APIs exports EP News Bureau Aug 14, 2019 The company’s net sales revenue (standalone) in Q1 ’FY 2019-20 stood at Rs 186.70 crore showing a growth of 25.4 per cent…
